Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Immunobiology|July 9, 2016
A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patientsClaudia Barzago, Josephine Lum, Paola Cavalcante, et al.
Journal of Neurology|April 17, 2026
Enhanced antibody detection via live cell-based assay among RIA negative myasthenia gravis patients: toward improved diagnosis and clinical correlatesElena Rinaldi, Elisa Puleo, Angela Di Maro, et al.
Immunobiology|January 3, 2016
Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infectionPaola Cavalcante, Barbara Galbardi, Sara Franzi, et al.
Oncoimmunology|June 27, 2013
The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysatesSerena Pellegatta, Marica Eoli, Simona Frigerio, et al.
Biomedicines|March 29, 2023
Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for AutosensitizationNicola Iacomino, Letizia Scandiffio, Fabio Conforti, et al.
Neurology|January 2, 2024
Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG StudyCarlo Antozzi, Jeffrey Guptill, Vera Bril, et al.
Oncotarget|December 10, 2017
Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?Paola Cavalcante, Stefania Marcuzzo, Sara Franzi, et al.
International Journal of Molecular Sciences|June 13, 2025
Blurred by a "Puff of Smoke"-A Case-Based Review on the Challenging Recognition of Coexisting CNS Demyelinating Disease and Moyamoya AngiopathyIsabella Canavero, Nicola Rifino, Carlo Antozzi, et al.
Acta Neuropathologica Communications|July 25, 2015
Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathyAlessandra Ruggieri, Francesco Brancati, Simona Zanotti, et al.
Oncoimmunology|April 11, 2018
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8<sup>+</sup> T cell activation in the presence of adjuvant temozolomideSerena Pellegatta, Marica Eoli, Valeria Cuccarini, et al.
Pageof 9